Comprehensive Proteomic Analysis Reveals Intermediate Stage of Non-Lesional Psoriatic Skin and Points out the Importance of Proteins Outside this Trend

To better understand the pathomechanism of psoriasis, a comparative proteomic analysis was performed with non-lesional and lesional skin from psoriasis patients and skin from healthy individuals. Strikingly, 79.9% of the proteins that were differentially expressed in lesional and healthy skin exhibi...

Teljes leírás

Elmentve itt :
Bibliográfiai részletek
Szerzők: Szél Edit
Bozó Renáta
Hunyadi-Gulyás Éva Csilla
Manczinger Máté
Szabó Kornélia Ágnes
Kemény Lajos
Csörgő Sándorné Bata Zsuzsanna
Groma Gergely
Dokumentumtípus: Cikk
Megjelent: 2019
Sorozat:SCIENTIFIC REPORTS 9
doi:10.1038/s41598-019-47774-5

mtmt:30774067
Online Access:http://publicatio.bibl.u-szeged.hu/17446
LEADER 02565nab a2200289 i 4500
001 publ17446
005 20191121152316.0
008 191121s2019 hu o 0|| zxx d
022 |a 2045-2322 
024 7 |a 10.1038/s41598-019-47774-5  |2 doi 
024 7 |a 30774067  |2 mtmt 
040 |a SZTE Publicatio Repozitórium  |b hun 
041 |a zxx 
100 1 |a Szél Edit 
245 1 0 |a Comprehensive Proteomic Analysis Reveals Intermediate Stage of Non-Lesional Psoriatic Skin and Points out the Importance of Proteins Outside this Trend  |h [elektronikus dokumentum] /  |c  Szél Edit 
260 |c 2019 
300 |a Terjedelem: 15 p-Azonosító: 11382 
490 0 |a SCIENTIFIC REPORTS  |v 9 
520 3 |a To better understand the pathomechanism of psoriasis, a comparative proteomic analysis was performed with non-lesional and lesional skin from psoriasis patients and skin from healthy individuals. Strikingly, 79.9% of the proteins that were differentially expressed in lesional and healthy skin exhibited expression levels in non-lesional skin that were within twofold of the levels observed in healthy and lesional skin, suggesting that non-lesional skin represents an intermediate stage. Proteins outside this trend were categorized into three groups: I. proteins in non-lesional skin exhibiting expression similar to lesional skin, which might be predisposing factors (i.e., CSE1L, GART, MYO18A and UGDH); II. proteins that were differentially expressed in non-lesional and lesional skin but not in healthy and lesional skin, which might be non-lesional characteristic alteration (i.e., CHCHD6, CHMP5, FLOT2, ITGA7, LEMD2, NOP56, PLVAP and RRAS); and III. proteins with contrasting differential expression in non-lesional and lesional skin compared to healthy skin, which might contribute to maintaining the non-lesional state (i.e., ITGA7, ITGA8, PLVAP, PSAPL1, SMARCA5 and XP32). Finally, proteins differentially expressed in lesions may indicate increased sensitivity to stimuli, peripheral nervous system alterations, furthermore MYBBP1A and PRKDC were identified as potential regulators of key pathomechanisms, including stress and immune response, proliferation and differentiation. 
700 0 1 |a Bozó Renáta  |e aut 
700 0 2 |a Hunyadi-Gulyás Éva Csilla  |e aut 
700 0 2 |a Manczinger Máté  |e aut 
700 0 2 |a Szabó Kornélia Ágnes  |e aut 
700 0 2 |a Kemény Lajos  |e aut 
700 0 2 |a Csörgő Sándorné Bata Zsuzsanna  |e aut 
700 0 2 |a Groma Gergely  |e aut 
856 4 0 |u http://publicatio.bibl.u-szeged.hu/17446/1/41598_2019_Article_47774.pdf  |z Dokumentum-elérés